Published in Genetics and Environmental Business Week, October 2nd, 2008
Clayton Hardman, CEO of BMGP also announced that the company is continuing to review the proposal from an Austrian based genetic engineering company and an independent research foundation. The proposal will grant us access to their patented viral painting technology, scientists, and laboratories to further explore BMGP's proprietary...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.